Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory transverse myelitis: evolving concepts.

Sean J Pittock1, Claudia F Lucchinetti

  • 1Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. Pittock.sean@mayo.edu

Current Opinion in Neurology
|August 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author response to letter.

Journal of the neurological sciences·2026
Same author

Neutrophil-microglia interaction drives motor dysfunction in a neuromyelitis optica model induced by subarachnoid AQP4-IgG.

The Journal of clinical investigation·2026
Same author

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination.

Journal of the neurological sciences·2026
Same author

Fourier transform infrared spectroscopy detects distinct TAR DNA-binding protein 43 signatures in frontotemporal lobar degeneration.

Frontiers in neuroscience·2025
Same author

Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

Journal of neurology·2025
Same author

Neutrophil-microglia interaction drives reversible motor dysfunction in neuromyelitis optica model induced by subarachnoid AQP4-IgG.

bioRxiv : the preprint server for biology·2025
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent advances in acute transverse myelitis include novel biomarkers like NMO-IgG. These markers improve understanding of inflammatory conditions and aid in diagnosing neuromyelitis optica spectrum disorders.

Area of Science:

  • Neurology
  • Immunology
  • Neuroinflammation

Background:

  • Acute transverse myelitis (ATM) is an inflammatory spinal cord disorder with diverse causes.
  • Understanding the pathogenesis of ATM is crucial for effective treatment.
  • Non-infectious inflammatory causes of ATM are increasingly recognized.

Purpose of the Study:

  • To review recent advances in inflammatory non-infectious ATM.
  • To highlight the role of serum autoantibody marker NMO-IgG in ATM.
  • To discuss novel biomarkers and their clinical applications in ATM.

Main Methods:

  • Review of recent scientific literature on ATM.
  • Focus on serological and cerebrospinal fluid biomarkers.
  • Analysis of diagnostic and prognostic implications of identified markers.

Related Experiment Videos

Main Results:

  • Neuromyelitis optica-IgG (NMO-IgG) is a key marker for neuromyelitis optica spectrum disorders, including longitudinally extensive transverse myelitis.
  • Other autoantibodies (e.g., anti-collapsin response-mediator protein-5, anti-amphiphysin) can indicate paraneoplastic ATM.
  • Inflammatory markers (e.g., interleukin-6) and CSF biomarkers (e.g., 14-3-3 protein) show potential for disease severity and prognosis.
  • Pediatric ATM differs from adult cases, often being longitudinally extensive with a better prognosis and lower recurrence risk.

Conclusions:

  • Novel biomarkers have significantly advanced the understanding of ATM.
  • These discoveries clarify the spectrum of disorders associated with inflammatory ATM.
  • A deeper appreciation of the complex and diverse pathogenetic basis of ATM has emerged.